An exploratory, randomised, controlled, parallel-group, open-label study to evaluate different dosing regimens of rabeprazole in controlling nocturnal heartburn (NT HB) symptoms in uninvestigated symptomatic gastroesophageal reflux disease (s-GERD) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

publication date

  • April 1, 2006